Of note, our findings that pharmacological inhibition of PI3K-III and SARA-dependent TGFβ signaling markedly ameliorated the defective neurogenesis caused by Wdr81 deficiency offer potential therapeutic strategies for treating the mental illness seen in WDR81-associated neurological disorders. This evidence concerns the gene TGFB1 and psychiatric disorder.